Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues
- 1 June 1996
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 41 (2) , 141-146
- https://doi.org/10.1007/bf01807159
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.1995
- Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancerInternational Journal of Cancer, 1995
- Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer.1995
- Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.Journal of Clinical Oncology, 1994
- High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.1993
- Multiparametric Prognostic Evaluation of Biological Factors in Primary Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Plasminogen activator system in human breast cancerInternational Journal of Cancer, 1992
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast CancerSeminars in Thrombosis and Hemostasis, 1991
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formationAnalytical Biochemistry, 1988